Press &Amp; Featuring Articles | Brain Matters Research

Call 561-374-8461 Se habla español

Press & Featuring Articles



T3D Boosts Cognition in Half of Alzheimer’s Patients

DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look into the exploratory, open label Phase 2a study. In an open-label exploratory study, 36 subjects with mild to moderate disease (MMSE 14-26) were randomized to receive 1 of 4 doses […]

vTv Therapeutics Completes Enrollment of Part A of Pivotal Phase 3 Trial Evaluating Azeliragon for the Treatment of Patients with Mild Alzheimer’s Disease

Phase 2b Trial Showed Positive Results In Slowing Cognitive Decline High Point, North Carolina (September 7, 2016) vTv Therapeutics Inc. (NASDAQ:VTVT) today announced the completion of enrollment for Part A of STEADFAST (Single Trial Evaluating Alzheimer’s Disease Following Addition to Symptomatic Therapy), vTv’s Phase 3 placebo-controlled trial of azeliragon, an oral antagonist of the Receptor […]

Federal Update: Rising Cost of Alzheimer’s Disease

Does this make sense?       Alzheimer’s disease is the most expensive disease facing our nation today and is set to increase like no other.       Currently our country spends over $203 billion per year caring for those with Alzheimer’s, with two thirds of those costs paid by Medicare and Medicaid. Without […]

The Power of Music on Memory

  Music can be powerful for people suffering from Alzheimer’s disease and related dementias, even in the very late stages of the disease. Music can affect mood, manage stress-induced agitation, stimulate positive interactions, facilitate cognitive function, and coordinate motor movements. Response to rhythm hardly requires any cognitive or mental processing. They are affected by the […]